464490 — QuadMedicine Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩202bn
- KR₩206bn
- KR₩9bn
Annual cashflow statement for QuadMedicine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -9,759 | -4,968 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 1,443 | 823 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 8,005 | 2,065 |
| Change in Accounts Receivable | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | 1,760 | 1,072 |
| Capital Expenditures | -11,912 | -3,505 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 4,626 | 56.2 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -7,286 | -3,449 |
| Financing Cash Flow Items | 196 | 74 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 6,262 | 8,061 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 757 | 5,814 |